Role of tissue plasminogen activator and plasminogen activator inhibitor polymorphism in myocardial infarction

Molecular Biology Reports

Volumn 38, Issue 4, 2011, Pages 2541-2548

  Ahmed, Waqas ^a   Malik, Meera ^b   Saeed, Imran ^c   Khan, Amina Ali ^b   Sadeque, Ahmed ^a   Kaleem, Umar ^c   Ahmed, Nuzhat ^d   Ajmal, Muhammad ^a,b   Azam, Maleeha ^a   Qamar, Raheel ^a,b  

^a COMSATS Institute of Information Technology ^*  (Pakistan)

^b SHIFA COLLEGE OF MEDICINE   (Pakistan)

^c Benazir Bhutto Hospital   (Pakistan)

^d UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

Coronary artery disease; Myocardial infarction; Plasminogen activator inhibitor; Tissue plasminogen activator

Indexed keywords

GUANINE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; ASIAN; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; DNA POLYMORPHISM; FAMILY HISTORY; FEMALE; GENE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HEART INFARCTION; HOMOZYGOTE; HUMAN; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PAKISTANI; POPULATION BASED CASE CONTROL STUDY; TISSUE PLASMINOGEN ACTIVATOR GENE; TISSUE PLASMINOGEN ACTIVATOR INHIBITOR GENE; AGAR GEL ELECTROPHORESIS; BLOOD; DRUG ANTAGONISM; GENETIC PREDISPOSITION; GENETICS; INDEL MUTATION; POLYMERASE CHAIN REACTION; RISK; RISK FACTOR; SMOKING;

CHOLESTEROL, HDL; ELECTROPHORESIS, AGAR GEL; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDEL MUTATION; MALE; MYOCARDIAL INFARCTION; ODDS RATIO; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMERASE CHAIN REACTION; RISK FACTORS; SMOKING; TISSUE PLASMINOGEN ACTIVATOR;

EID: 79960938932     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0392-8     Document Type: Article

References (33)

1. Joshi P, Islam S, Pais P, Reddy S, Dorairaj P, Kazmi K, Pandey MR, Haque S, Mendis S, Rangarajan S, Yusuf S (2007) Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. JAMA 297:286-294
2. Bronic A, Ferencak G, Zadro R, Stavljenic-Rukavina A, Bernat R (2009) Impact of FXIII-A Val34Leu polymorphism on coronary artery disease in Croatian patients. Mol Biol Rep 36:1-5
3. Pinchuk M (2007) World health statistics 2007. WHO Press, Geneva
4. Theakston F (2008) World health statistics 2008. WHO Press, Geneva
5. Lewandrowski K, Chen A, Januzzi J (2002) Cardiac markers for myocardial infarction: a brief review. Am J Clin Pathol 118:S93-S99
6. Ni Y, Zhang J (2009) Association of deoxyribonuclease I genetic polymorphisms with myocardial infarction in Han Chinese. Mol Biol Rep 36:595-601
7. Gao H, Zhang Z, Zhang J, Zhao N, Li Q, Bai M (2010) Association of LT-alpha Ala252Gly gene polymorphism and the genetic predisposition of coronary heart disease in Chinese. Mol Biol Rep 37:47-50
8. Margaglione M, Cappucci G, Colaizzo D, Giuliani N, Vecchione G, Grandone E, Pennelli O, Di Minno G (1998) The PAI-1 gene locus 4G/5G polymorphism is associated with a family history of coronary artery disease. Arterioscler Thromb Vasc Biol 18:152-156
9. Crainich P, Jenny NS, Tang Z, Arnold AM, Kuller LH, Manolio T, Sharrett AR, Tracy RP (2003) Lack of association of the plasminogen activator inhibitor-1 4G/5G promoter polymorphism with cardiovascular disease in the elderly. J Thromb Haemost 1:1799-1804
10. Voetsch B, Loscalzo J (2004) Genetic determinants of arterial thrombosis. Arterioscler Thromb Vasc Biol 24:216-229
11. de Lange M, Snieder H, Ariens RA, Spector TD, Grant PJ (2001) The genetics of haemostasis: a twin study. Lancet 357:101-105
12. Robinson SD, Ludlam CA, Boon NA, Newby DE (2006) Tissue plasminogen activator genetic polymorphisms do not influence tissue plasminogen activator release in patients with coronary heart disease. J Thromb Haemost 4:2262-2269
13. Ridker PM, Baker MT, Hennekens CH, Stampfer MJ, Vaughan DE (1997) Alu-repeat polymorphism in the gene coding for tissue-type plasminogen activator (t-PA) and risks of myocardial infarction among middle-aged men. Arterioscler Thromb Vasc Biol 17:1687-16890
14. Nakazawa I, Nakajima T, Ishigami T, Umemura S, Emi M (2001) Linkage disequilibrium and haplotype analysis among eight novel single-nucleotide polymorphisms in the human tissue-type plasminogen activator (t-PA) gene. J Hum Genet 46:367-371
15. Falk E (1999) Stable versus unstable atherosclerosis: clinical aspects. Am Heart J 138:S421-S425
16. Soysal D, Emuroglu T, Biceroglu S, Cevik C, Ulusoy S, Cengiz NK, Cetinkaya GS (2006) The association of Plasma PAI-1 and t-PA antigen concentrations with related cardiac risk factors in their first-degree relatives. Turkiye Klinikleri J Cardiovasc Sci 18:4-12
17. Eriksson P, Kallin B, van 't Hooft FM, Bavenholm P, Hamsten A (1995) Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci USA 92:1851-1855
18. Sambrook J, Russell DW (2001) Molecular cloning: a laboratory manual, vols I and II, 3rd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
19. Van der Bom JG, de Knijff P, Haverkate F, Bots ML, Meijer P, de Jong PT, Hofman A, Kluft C, Grobbee DE (1997) Tissue plasminogen activator and risk of myocardial infarction. The Rotterdam Study. Circulation 95:2623-2627
20. Anderson JL, Muhlestein JB, Habashi J, Carlquist JF, Bair TL, Elmer SP, Davis BP (1999) Lack of association of a common polymorphism of the plasminogen activator inhibitor-1 gene with coronary artery disease and myocardial infarction. J Am Coll Cardiol 34:1778-1783
21. Castellano M (2006) Geographic ancestry, angiotensinogen gene polymorphism, and cardiovascular risk. Hypertension 48:562-563
22. Schoenhard JA, Asselbergs FW, Poku KA, Stocki SA, Gordon S, Vaughan DE, Brown NJ, Moore JH, Williams SM (2008) Male-female differences in the genetic regulation of t-PA and PAI-1 levels in a Ghanaian population. Hum Genet 124:479-488
23. Petrovic D, Globocnik-Petrovic M, Peterlin B (2003) 4G4G genotype of PAI-1 gene promoter polymorphism is not associated with myocardial infarction in Caucasians with type-2 diabetes. Cardiology 100:157-158
24. Hooper WC, Lally C, Austin H, Renshaw M, Dilley A, Wenger NK, Phillips DJ, Whitsett C, Rawlins P, Evatt BL (2000) The role of the t-PA I/D and PAI-1 4G/5G polymorphisms in African-American adults with a diagnosis of myocardial infarction or venous thromboembolism. Thromb Res 99:223-230
25. Doggen CJ, Bertina RM, Cats VM, Reitsma PH, Rosendaal FR (1999) The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with myocardial infarction. Thromb Haemost 82:115-120
26. Steeds R, Adams M, Smith P, Channer K, Samani NJ (1998) Distribution of tissue plasminogen activator insertion/deletion polymorphism in myocardial infarction and control subjects. Thromb Haemost 79:980-984
27. Hafer-Macko CE, Ivey FM, Sorkin JD, Macko RF (2007) Microvascular tissue plasminogen activator is reduced in diabetic neuropathy. Neurology 69:268-274
28. Jafary MH, Samad A, Ishaq M, Jawaid SA, Ahmed M, Vohra EA (2007) Profile of acute myocardial infarction (AMI) in Pakistan. Pak J Med Sci 23:485-489
29. Ismail J, Jafar TH, Jafary FH, White F, Faruqui AM, Chaturvedi N (2004) Risk factors for non-fatal myocardial infarction in young South Asian adults. Heart 90:259-263
30. Juhan-Vague I, Morange PE, Frere C, Aillaud MF, Alessi MC, Hawe E, Boquist S, Tornvall P, Yudkin JS, Tremoli E, Margaglione M, Di Minno G, Hamsten A, Humphries SE, HIFMECH Study Group (2003) The plasminogen activator inhibitor-1-675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH study. J Thromb Haemost 1:2322-2329
31. Salonen JT, Salonen R, Seppänen K, Rauramaa R, Tuomilehto J (1991) HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction. A prospective population study in eastern Finnish men. Circulation 84:129-139
32. Yamada Y, Izawa H, Ichihara S, Takatsu F, Ishihara H, Hirayama H, Sone T, Tanaka M, Yokota M (2002) Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 347:1916-1923
33. Glueck CJ, Phillips H, Cameron D, Wang P, Fontaine RN, Moore SK, Sieve-Smith L, Tracy T (2000) The 4G/4G polymorphism of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: an independent risk factor for serious pregnancy complications. Metabolism 49:845-852